Ultra-Processed Foods, Palatability, Appetite, and Gastrointestinal Transit
20 maj 2026 uppdaterad av: Richard Mattes, Purdue University
Ultra-Processed Foods - Palatability and Appetite
The goal of this clinical trial is to learn how food processing level affects appetite and gastrointestinal transit time when meal palatability is changed.
Participants will complete one screening visit and four test visits.
During each test visit, participants will consume one of four meals that differ by food processing level and palatability: high-palatability ultra-processed food, low-palatability ultra-processed food, high-palatability non-ultra-processed food, or low-palatability non-ultra-processed food.
The main questions this study aims to answer are whether food processing and palatability affect appetite sensations and gastrointestinal transit time.
Participants will rate appetite sensations during each test visit and provide breath samples to measure gastrointestinal transit time.
Studieöversikt
Status
Avslutad
Detaljerad beskrivning
This is a randomized crossover trial examining the effects of food processing level and palatability on appetite and gastrointestinal transit time.
Participants will complete a screening visit followed by four test visits, with each test visit separated by at least one week.
Each participant will consume all four test meals: high-palatability ultra-processed food, low-palatability ultra-processed food, high-palatability non-ultra-processed food, and low-palatability non-ultra-processed food.
Palatability will be reduced by adding bitter melon powder to the low-palatability meals.
During each test visit, participants will consume the assigned test meal containing lactulose as a marker of gastrointestinal transit time.
Breath samples will be collected to assess orocecal transit time using hydrogen analysis.
Participants will also rate meal palatability and appetite sensations, including hunger, fullness, desire to eat, amount they could eat, and thirst, using visual analog scales during the test visit.
Studietyp
Interventionell
Inskrivning (Faktisk)
40
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Indiana
-
West Lafayette, Indiana, Förenta staterna, 47907
- Purdue University
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Ja
Beskrivning
Inclusion Criteria:
- Individuals aged 18 to 60 years.
- Any sex, gender, or orientation.
- Self-reported good health.
- No medication use.
- No allergies or food sensitivities to any of the foods used in the study.
- No anticipated change in physical activity during the study period.
- Willingness to complete all planned study activities, including the screening visit and four test visits.
- At screening, participants must rate the selected high-palatability foods between 60 and 90 on a 100-unit visual analog scale, where 100 = extremely palatable.
- At screening, participants must rate the selected low-palatability foods between 10 and 40 on a 100-unit visual analog scale.
Exclusion Criteria:
- Younger than 18 years or older than 60 years.
- Current medication use.
- Allergies or food sensitivities to any study foods.
- Not meeting the required palatability rating ranges during screening.
- Anticipated change in physical activity during the study period.
- Not self-reporting good health.
- Unwillingness or inability to complete the planned study activities.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Palatable Ultra-Processed Food
Participants will consume a palatable ultra-processed test meal during one study visit.
The meal will be used to assess appetite sensations, palatability ratings, and gastrointestinal transit time.
|
Participants will consume a palatable ultra-processed test meal during one study visit.
The meal will consist of commonly available ultra-processed food items and will be used to assess appetite sensations, meal palatability, and gastrointestinal transit time.
|
|
Experimentell: Unpalatable Ultra-Processed Food
Participants will consume an unpalatable ultra-processed test meal during one study visit.
Palatability will be reduced by adding bitter melon powder.
The meal will be used to assess appetite sensations, palatability ratings, and gastrointestinal transit time.
|
Participants will consume an unpalatable ultra-processed test meal during one study visit.
Palatability will be reduced by adding organic bitter melon powder to the ultra-processed meal.
The meal will be used to assess appetite sensations, meal palatability, and gastrointestinal transit time.
|
|
Experimentell: Palatable Non-Ultra-Processed Food
Participants will consume a palatable non-ultra-processed test meal during one study visit.
The meal will be used to assess appetite sensations, palatability ratings, and gastrointestinal transit time.
|
Participants will consume a palatable non-ultra-processed test meal during one study visit.
The meal will consist of commonly available non-ultra-processed food items and will be used to assess appetite sensations, meal palatability, and gastrointestinal transit time.
|
|
Experimentell: Unpalatable Non-Ultra-Processed Food
Participants will consume a unpalatable non-ultra-processed test meal during one study visit.
Palatability will be reduced by adding bitter melon powder.
The meal will be used to assess appetite sensations, palatability ratings, and gastrointestinal transit time.
|
Participants will consume an unpalatable non-ultra-processed test meal during one study visit.
Palatability will be reduced by adding organic bitter melon powder to the non-ultra-processed meal.
The meal will be used to assess appetite sensations, meal palatability, and gastrointestinal transit time.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Orocecal Transit Time
Tidsram: During each test visit, up to 4.5 hours after meal consumption
|
Orocecal transit time will be assessed using hydrogen analysis of end-alveolar breath samples collected after consumption of each test meal.
Each test meal will contain lactulose as a marker of gastrointestinal transit time.
|
During each test visit, up to 4.5 hours after meal consumption
|
|
Appetite Sensations
Tidsram: During each test visit, up to 4.5 hours after meal consumption
|
Appetite sensations, including hunger, fullness, desire to eat, prospective food consumption, and thirst, will be assessed using 100-mm visual analog scales during each test visit after consumption of the assigned test meal every 30 minutes.
Each visual analog scale ranges from 0 to 100 mm, with higher scores indicating a greater intensity of the rated sensation.
Higher scores are not inherently better or worse outcomes, but reflect greater hunger, fullness, desire to eat, prospective food consumption, or thirst, depending on the item.
|
During each test visit, up to 4.5 hours after meal consumption
|
|
Meal Palatability Ratings
Tidsram: During each test visit, up to 4.5 hours after meal consumption
|
Meal palatability will be assessed using a 100-mm general labeled magnitude scale during each study visit.
The scale ranges from 0 to 100 mm, with 0 mm anchored by "most disliked sensation imaginable," 50 mm anchored by "neutral," and 100 mm anchored by "most liked sensation imaginable."
Higher scores indicate greater liking of the test meal and therefore a more favorable palatability rating.
|
During each test visit, up to 4.5 hours after meal consumption
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
24 september 2024
Primärt slutförande (Faktisk)
30 april 2026
Avslutad studie (Faktisk)
30 april 2026
Studieregistreringsdatum
Först inskickad
14 maj 2026
Först inskickad som uppfyllde QC-kriterierna
14 maj 2026
Första postat (Faktisk)
20 maj 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
22 maj 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
20 maj 2026
Senast verifierad
1 maj 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- IRB-2024-450
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
IPD-planbeskrivning
Individual participant data will not be shared because the current IRB-approved protocol does not include a formal plan for external individual participant data sharing.
Study data will be de-identified for analysis, and identifying information will be stored separately from study data.
Code numbers linking participants to their data will be destroyed according to the approved protocol.
No information by which participants can be identified will be released or published.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .